This is an attempt to summarize all major publications in pediatric cardiology, pediatric cardiac surgery, anesthesia, and intensive care for the year 2015. The table does include two papers that appeared late in 2014. This selection is potentially useful for those who wish to do a quick overview of all articles that were published in the preceding year. Given the diversity of sources of literature in pediatric cardiac sciences, it is difficult to keep track of what is potentially useful.
The list is useful for fellows to select papers for in-depth reviews in journal clubs.
Four papers have been chosen for a detailed review as "Selected Summaries."
We would value critical feedback on what could have been additionally included and what perhaps did not merit inclusion in the list. This feedback can be sent to the editor via email. Sixteen patients with severe symptomatic pulmonary arterial hypertension (PAH) on optimal prostanoid therapy underwent balloon atrial septostomy. Six had repeat septostomy and two had stenting. Patients with BAS had improved cardiac output and lower saturation. One-year survival rate following the procedure was 64%. Some could be bridged to transplant. The nonresponders were male and had no improvement in cardiac output despite the increase in LVEDP 2 A new predictive equation for oxygen consumption in children and adults with congenital and acquired heart disease. Seckeler MD, Hirsch R, Beekman RH 3 rd , Goldstein BH. Heart. 2015; 101:517-24 Retrospective followed by prospective validation Development of a more accurate predictive equation for oxygen consumption (VO2) in children and adults undergoing cardiac catheterisation The authors retrospectively evaluated 502 patients (0-59 years) who underwent cardiac catheterization with measured VO 2 (M-VO 2 ) and compared M-VO 2 with VO 2 from the LaFarge equations (LF-VO 2 ). LF-VO 2 was inaccurate in 42% of Group 1 (age <3 years; N=201) and 13% of Group 2 (age ≥3 years; N=301). The data varied in single ventricle and biventricular physiology. The factors associated with the inaccuracy were analyzed and a new equation was derived. The new equation was prospectively tested in 100 prospective patients and found comparable to directly measured VO 2 3
No Reference Study design Study question Conclusion
Atenolol versus losartan in children and young adults with Marfan's syndrome. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD et al. N Engl J Med. 2014; 371:2061-71 Randomized control trial
Which is the better drug between Losartan and Atenolol in slowing aortic-root enlargement in children and young adults with Marfan's syndrome?
Six hundred and eight patients with Marfan's syndrome (6 month to 25 years, aortic root >3 SD) from 21 centers were enrolled. The rate of change of aortic root diameter did not vary in these two groups. The 3-year rates of aortic-root surgery, aortic dissection, death, and a composite of these events did not differ significantly between the two treatment groups Twenty-eight patients with corrected ASD were studied and compared with 45 patients with SSc. All underwent a rest and bicycle stress echocardiography to obtain baseline right heart characteristics and dynamic PVR. They were followed up for a median of 3.7/2.4 years.
In the post-ASD closure cohort, no patient developed PAH. Dynamic PVR was significantly associated with right atrial dilatation at latest follow-up. Dynamic PVR predicted development of PAH in patients with SSc (30% developed PAH) A cohort of 47 patients underwent PDA closure with AVP IV; median age 7 months (range: 3-23 months) and median weight 6.9 kg (range: 4.1-17.0 kg). The AVP size was ~2 mm more than mean maximal ductal diameter. There was complete early occlusion in all cases with one instance of device embolization. The patients were all found to be well at a mean follow-up of 3.4 years. The AVP IV was found to be safe and effective for tubular ducts. Retrospective analysis of 663 patients with epicardial pacemaker leads. The patients divided in single and biventricular group. Overall atrial lead survival rates at 1 year, 2 years, 5 years, and 10 years (99%, 93%, 83%, and 72%) were comparable with ventricular lead survival rates (97%, 90%, 74%, and 60%). SV palliation and an earlier era of lead implantation (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) was significantly associated with ventricular, but not atrial lead malfunction 21 Plasma exchange effectively removes 52-and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart block. Transfusion. 2015; 55:1782 -1786 Prospective trial
What is the efficacy of plasma exchange (PE) in removing 52-and 60-kDa anti-Ro/ SSA and anti-La/SSB antibodies in pregnant women with CHB treated with combined therapy including PE, intravenous immunoglobulins, and steroids 10 consecutive pregnant women with congenital heart block showed a significant decrease in mean antibody levels after plasma exchange. PE treatment was found to have a long-term efficacy in all the women positive for anti-La/SSB antibodies and in most of the women positive for 52-kDa and 60-kDa anti-Ro/SSA antibodies. Plasma exchange shows promise in reversal of CHB in mothers with anti-Ro/anti-La antibodies 22 Reduced fetal cerebral oxygen consumption is associated with smaller brain size in fetuses with congenital heart disease. Sun L, Macgowan CK, Sled JG, Yoo SJ, Manlhiot C, Porayette P, et al. Circulation. 2015; 131:1313-23 Prospective cohort study
What is the relation between reduced cerebral oxygenation and brain growth in fetuses with CHD?
The study measured fetal brain size, oxygen saturation, and blood flow in the major vessels of the fetal circulation in 30 late-gestation fetuses with CHD and 30 normal controls using phase-contrast magnetic resonance imaging and T2 mapping. In fetuses with CHD, reduction in umbilical vein oxygen content (P<0.001) and failure of the normal streaming of oxygenated blood from the placenta to the ascending aorta were associated with a mean reduction in ascending aortic saturation of 10% (P<0.001) and 15% reduction in cerebral oxygen delivery (P=0.08). This resulted in 32% reduction in cerebral VO 2 in CHD fetuses (P<0.001), which was associated with a 13% reduction in fetal brain volume (P<0.001). One hundred and thirty-four patients with severe pulmonary hypertension were prospectively recruited over a 12-year period and were followed up from first diagnostic right heart catheterization to either death or the end of the study. Survival rate in the total cohort was 86.4% after 1 year, 72.9% after 3 years, and 65.4% after 5 years. Significantly better survival was seen in the group of patients with PAH associated with congenital heart disease than others such as idiopathic PAH and heritable PAH. Pulmonary hypertension however remained a fatal disease, despite the modern targeted therapies Ninety-five patients with severe pulmonary hypertension were studied. They were 43±11 years old, mean pulmonary arterial pressure was 54±14 mmHg, and pulmonary vascular resistance index was 25±12 Wood units m 2 . Over an average follow-up of 5 years, the composite end point occurred in 34 patients, including 26 deaths and 8 patients requiring lung transplant. On multivariable analysis, RV systolic dysfunction grade, severe RA enlargement (HR: 3.0; 95% CI: 1.3-8.1; P=0.009), and systemic blood pressure <110 mmHg (HR: 3.3; 95% CI: 1.5-9.4; P<0.001) were independently associated with poor outcome. A score was proposed based on these three variables that need further validation 27 Thirty-four patients from a cohort of 600 patients undergoing congenital heart surgery required repeated CPB and were enrolled into the study. The mean age was 2 years and the mean body weight was 9.9 kg. Twenty-six patients out of these 34 were patients weaned from the CPB after additional surgical repair with re-bypass, one of whom died in the ICU. Of the remaining eight patients who were weaned from the CPB after medical treatment, there were three mortalities. Though repeat CPB was associated with higher mortality, patients who had a residual lesion that could be surgically corrected during repeat CPB had better outcomes than those that were on conservative management What are the outcomes and risk factors for heart transplantation in children with congenital heart disease?
A total of 124 children with congenital heart disease who underwent heart transplantation were studied. Thirteen percent underwent primary heart transplantation, and 87% had prior surgical repair/palliation (27% Fontan). Ten years after heart transplantation, 13% of patients had undergone retransplantation, 43% of patients had died without retransplantation, and 44% of patients were alive without retransplantation. Overall survival after 15 years was only 41%. On multivariable analysis, risk factors for earlyphase mortality were age less than 1 year and prolonged cardiopulmonary bypass What is the efficacy and safety of a miniaturized, fully self-contained leadless pacemaker?
An active-fixation leadless cardiac pacemaker implanted in a cohort of 526 patients who required permanent singlechamber ventricular pacing with a success rate of 95.8% (504 patients). The intention to treat primary efficacy end point was met in 270 of the 300 patients in the primary cohort (90.0%) and the primary safety end point was met in 280 of the 300 patients (93.3%). At 6 months, devicerelated serious adverse events were observed in 6.7% of the patients; events included device dislodgement with percutaneous retrieval (in 1.7%), cardiac perforation (in 1.3%), and pacing-threshold elevation requiring percutaneous retrieval and device replacement (in 1.3%). What is the reliability and feasibility of a new score to assess the risk of rejection in pediatric heart transplantation recipients during the first post-transplant year?
A total of 3,195 pediatric patients who underwent isolated orthotopic heart transplantation were divided into a derivation cohort (N=2,686) and a validation (N=509) cohort. A 9-point risk score using three variables (age, cardiac diagnosis, and panel reactive antibody) was developed. A higher score was associated with an increased rate of rejection (10.6% in score = 0 vs. 40% in score = 9 in the validation cohort; P< 0.01). The rejection score is accurate in determining the risk of early rejection in pediatric heart transplantation recipients 47 A smartphone application to diagnose the mechanism of pediatric supraventricular tachycardia. Reason for choosing study: Public health impact.
Type of study: Prospective cohort study.
Study question: Can a nurse-led screening program using a handheld echo machine and simplified criteria (focused cardiac ultrasound or FCU) be effective as a screening tool in the detection of rheumatic heart disease (RHD)?
Background: RHD remains a public health problem in many parts of the developing world. Early detection aids secondary prevention by the administration of penicillin prophylaxis. Clinical examination remains poor in detecting RHD and detailed echocardiography by a cardiologist remains resource intensive in low-resource settings.
Aim: (i) To test the adequacy of the pocket echo machine in RHD surveillance, (ii) to assess the proficiency of nurses after brief training in carrying out FCU, (iii) to assess the sensitivity and specificity of using simplified echo criteria in detecting RHD in comparison with a detailed echocardiogram carried out by an experienced cardiologist (reference approach).
Methodology: A total of 1,217 school children were prospectively studied with focused cardiac ultrasound using a pocket-sized echo machine by nursing personnel guided by simplified echo diagnostic criteria to detect RHD. The criteria used were MR jet length >2 cm or the presence of AR. The mean age of the children was 9.6 ± 1 years with an equal male:female ratio.
The echo criteria were selected based on a preliminary study that looked at six different criteria in 189 children with and without RHD. A focused cardiac ultrasound (FCU) was performed using a V-scan (GE Medical Systems) handheld echo machine. Training of the two nurses involved 3 days of theoretical teaching and 30 hours of hands-on training along with tailored tutorship. The FCU performed by the nurses was compared with the detailed echocardiogram performed by the cardiologist (reference approach). Statistical analysis mainly focussed on the sensitivity, specificity, and interobserver variability of FCU.
Results and limitations: The overall sensitivity of this strategy was ~80% with a specificity of 90% thereby making it a possible way of RHD screening in lowresource settings. However, there need to be secondary prophylaxis programs in place to treat detected RHD. Also, there may be the problem of over detection leading to over treatment. However, this needs to be viewed in the public health context where more elaborate testing may be prohibitive in terms of cost and human resource.
Conclusion: This study suggests more large scale testing of this strategy before it can be implemented as a policy.
Comment: The study demonstrates the feasibility of task-shifting or task-sharing of a specific activity and is particularly suited for application in large-scale surveys in resource-constrained environments. In the past decade, there is increasing emphasis on echocardiography as a screening tool for "accurate" estimation of RHD disease burden. Background: The last few decades have seen remarkable advances in surgical techniques and postoperative care of patients with congenital heart disease. In addition, early detection along with concomitant advances in cardiac catheterization have improved both the survival and quality of life of patients with CHD.
Aim: To determine the overall trends in survival and freedom from re operation in congenital heart surgery over the last four decades.
Methodology: A total of 7,038 patients (<16 yrs) who underwent CHD surgery in Rikshospitalet, Oslo over last 4 decades were analyzed. The demographics, diagnosis, type of surgery, and outcomes were recorded. Fifty-three percent were classified as simple CHD and 41% were classified as complex, and the rest were miscellaneous.
Results and limitations: The number of patients undergoing surgery increased progressively whilst the age at operation decreased from a median of 1.6 year in 1971-1979 to 0.19 year in 2000-2011. There was a fall in the numbers of certain procedures due to the advent of cardiac catheterization and nonsurgical management of these lesions.
The outcome progressively improved with recent 1 year and 5 years survival rates of more than 95%. There was continuing improvement in 1-year survival even through the last decade (95.3% in 2005-2009 versus 99.6% in 2010-2011) . The cumulative freedom from reoperation in complex CHD in the most recent decade was found to be ~75% at 5 years. This was despite increasing complexity of the primary surgery and is partly attributable to a significant decrease in palliative procedures. Long-term cumulative survival to 16 years of age also increased from 62% (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) to 87% (1990-2011) .
Conclusion: The study showed highly significant, sequential, and continuing improvements in survival and reductions in reoperation after CHD surgery.
Comment: This study should be considered a benchmark for others to emulate. The exceptional results are reflective of an excellent comprehensive pediatric cardiac service from a country that has the highest human development index in the world.
The results of this study may not be applicable to many other parts of the world, specifically the low resource environments of low-and middle-income countries where an increasing number of operations are now being performed. The specific challenges here relate to poor preoperative condition, resource limitations for perioperative care and limitations in quality of follow-up care. However, these are standards worth aspiring for.
Breaking the limit: Mechanical characterization of overexpanded balloon expandable stents used in congenital heart disease. Bratincsak A, Moore JW, Gulker B, Choules B, Koren L, El-Said HG. Congenit Heart Dis. 2015;10:51-63.
Reason for choosing study: Study addresses the very important issue of the dilatability of stents in infants and young children with CHD.
Type of study: In vitro experimental study.
Study question: Can stents implanted in infants and children be serially dilated to significantly larger diameters without losing integrity and important mechanical characteristics?
Background: Intravascular stent implantation offers a relatively low-risk alternative to open heart surgery in young patients with congenital heart disease but a major limiting factor has been the 'inability' of routinely available stents to keep up with the somatic growth in infants and young children.
Aim: To assess the expansion potential of commonly used balloon expandable stents and to characterize the mechanical parameters of these stents at the maximum expansion diameter (MED).
Methodology: Sixteen types of commonly used stents were dilated 1.3-2.4 (mean 1.7) times the recommended diameter. For mechanical testing, all stents were expanded unconstrained in a 37°C ± 2°C water bath over an appropriately sized guide wire. The stent diameter Annals of Pediatric Cardiology 2016 Vol 9 Issue 1 during expansion was confirmed by laser micrometer measurements.
To test the mechanical parameters, the stents were dilated in a serial fashion: First, the stents were inflated to the MED, which is defined as the maximum diameter recommended by the respective manufacturers. Then, the stents were expanded beyond the MED using a series of noncompliant balloons in sequential increments of 2 mm until the stent fracture occurred. For each measurement, at least three stents (ranged from 3 to 7) were used, with a few exceptions.
Results and limitations: Stents could be dilated to an average of 1.7 times the NED (range from 1.3 to 2.4 times) without losing mechanical integrity. Cook and ev3 stents showed negligible length change at MED; however, significant change was demonstrated with Cordis and Atrium stents. The radial strength was found better at higher diameters and the stents were found to maintain good mechanical characteristics when dilated beyond their recommended NED.
These results support the use of balloon expandable stents in smaller vessels that require future serial redilation. The obvious limitation is the in vitro nature of the study.
Comment: Stents have become an indispensable tool for the pediatric cardiologists. The specific challenges in stents include overcoming technical challenges with deployment in small children and allowing for progressive increase in size as the child grows. Unfortunately, few stents are specifically manufactured for specific use in children with cardiovascular disease. Stents are primarily manufactured for peripheral vascular disease in adults and for locations outside the vascular system because this is a much larger market. This in vitro study specifically examines the effect of progressive dilation above the recommended maximum expansion diameter recommended for a number of commercially available stents and generates useful information on feasibility of dilation beyond MED, radial strength, and shortening. The variations in the constraining influence of surrounding structures when stents are implanted in vivo are likely to be considerable (from soft structures such as atrial septum to calcified rigid conduits). Therefore, the results of this study may not consistently apply to real-life implantations.
A new predictive equation for oxygen consumption in children and adults with congenital and acquired heart disease. Seckeler MD, Hirsch R, Beekman RH 3 rd , Goldstein BH. Heart. 2015;101:517-24.
Reason for choosing study: This study attempts to improve the existing Lafarge equation used to calculate oxygen consumption for estimation of cardiac output by Fick's principle.
Type of study: Retrospective followed by prospective validation.
Study question: Development of a new predictive equation for oxygen consumption (VO 2 ) in children and adults with congenital and acquired heart disease.
Background: Estimation of cardiac index and therefore pulmonary and systemic blood flow and vascular resistances relies on Fick's principle that routinely uses oxygen consumption data derived from the archaic Lafarge table that has not been validated in children aged <3 years and has been shown to be inaccurate in current day practice. Although it is theoretically possible to measure VO 2 (mVO 2 ) in every patient, this is cumbersome and time-consuming.
Aim: To identify factors associated with inaccuracies in assumed VO2 using the Lafarge equations, and more importantly, to develop and validate a new VO2 predictive equation for use in patients of all ages.
Methodology: The authors retrospectively evaluated 502 patients (0-59 yrs) who underwent cardiac catheterization with measured VO 2 (M-VO 2 ) and compared M-VO 2 with VO 2 from the LaFarge equations (LF-VO 2 ). The factors associated with the inaccuracy were analyzed and a new equation was derived.
The new equation was prospectively tested in 100 patients and compared with M-VO 2 .
Results and limitations: LF-VO 2 was inaccurate in 42% of Group 1 (age <3 y; N = 201) and 13% of Group 2 (age ≥3 y; N = 301). The data varied in single ventricle and biventricular physiology. Multiple logistic regression identified younger age and single ventricle anatomy in Group 1 and anemia in Group 2 as significant predictors of an inaccurate LF-VO2; critical illness was of borderline significance in both groups.
A new equation was formulated as follows: The VO 2 calculated with the new equation was comparable with the M-VO 2 . In the age group < 3 years the new equation proved more accurate than the Lafarge equation and in the group ≥3 years it was comparable in accuracy. The authors have also laid out tables with VO 2 values for single ventricle and biventricular groups based on their study data.
This study is limited by relatively small numbers from a single center particularly in the prospective validation phase. It will need further validation and if found to be reliable will be of great utility in modern day cardiac catheterization.
